Terms: = Thyroid cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Diagnosis
4 results:
1. Peritumoral/vascular expression of PSMA as a diagnostic marker in hepatic lesions.
Chen W; Lee Z; Awadallah A; Zhou L; Xin W
Diagn Pathol; 2020 Jul; 15(1):92. PubMed ID: 32703222
[TBL] [Abstract] [Full Text] [Related]
2. Expression of fhit, p16, p53 and EGFR as prognostic markers in thyroid tumors of uncertain malignant potential.
Koc M; Aktimur R; Kagan Gokakin A; Atabey M; Koyuncu A; Elagoz S; Topcu O
J BUON; 2015; 20(2):567-72. PubMed ID: 26011351
[TBL] [Abstract] [Full Text] [Related]
3. Diagnostic value of 16 cellular tumor markers for metastatic thyroid cancer: an immunohistochemical study.
Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Zhan S; Xie K; Li QQ
Anticancer Res; 2011 Oct; 31(10):3433-40. PubMed ID: 21965758
[TBL] [Abstract] [Full Text] [Related]
4. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
[TBL] [Abstract] [Full Text] [Related]
